-
EP3609578
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3609578
| EP3609578 - PHARMACEUTICAL COMBINATION AND ITS USE FOR TREATING SYNUCLEINOPATHIES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 25.11.2022 Database last updated on 31.08.2024 | |
| Former | Request for examination was made Status updated on 17.01.2020 | ||
| Former | The international publication has been made Status updated on 20.10.2018 | Most recent event Tooltip | 06.08.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Chase Therapeutics Corporation 1825 K Street N.W. Suite 520 Washington, DC 20006 / US | [2020/08] | Inventor(s) | 01 /
CHASE, Thomas, N. 1825 K Street N.W. Suite 520 Washington, DC 20006 / US | 02 /
CLARENCE-SMITH, Kathleen, E. 1825 K Street N.W. Suite 520 Washington, DC 20006 / US | [2020/08] | Representative(s) | Trupiano, Federica Marietti, Gislon e Trupiano S.r.l. Via Larga, 16 20122 Milano / IT | [2020/08] | Application number, filing date | 18784304.0 | 11.04.2018 | [2020/08] | WO2018US27155 | Priority number, date | US201762485082P | 13.04.2017 Original published format: US 201762485082 P | [2020/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018191408 | Date: | 18.10.2018 | Language: | EN | [2018/42] | Type: | A1 Application with search report | No.: | EP3609578 | Date: | 19.02.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.10.2018 takes the place of the publication of the European patent application. | [2020/08] | Search report(s) | International search report - published on: | US | 18.10.2018 | (Supplementary) European search report - dispatched on: | EP | 08.02.2021 | Classification | IPC: | A61K31/138, A61P25/00, A61P25/16, A61K9/00, A61K31/428, A61K9/20, A61K9/24 | [2021/10] | CPC: |
A61P25/00 (EP);
A61K31/428 (EP,US);
A61K31/138 (EP,US);
A61P25/16 (EP,US);
A61K9/2054 (EP);
A61K9/209 (EP)
| C-Set: |
A61K31/138, A61K2300/00 (EP);
A61K31/428, A61K2300/00 (EP) |
| Former IPC [2020/08] | A61P25/00, A61P25/16, A61K31/00, A61K9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/08] | Extension states | BA | 12.11.2019 | ME | 12.11.2019 | Validation states | KH | 12.11.2019 | MA | 12.11.2019 | MD | 12.11.2019 | TN | 12.11.2019 | Title | German: | PHARMAZEUTISCHE KOMBINATION UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SYNUKLEINOPATHIEN | [2020/08] | English: | PHARMACEUTICAL COMBINATION AND ITS USE FOR TREATING SYNUCLEINOPATHIES | [2020/08] | French: | COMBINAISON PHARMACEUTIQUE ET SON UTILISATION POUR LE TRAITEMENT DE SYNUCLÉINOPATHIES | [2020/08] | Entry into regional phase | 12.11.2019 | National basic fee paid | 12.11.2019 | Search fee paid | 12.11.2019 | Designation fee(s) paid | 12.11.2019 | Examination fee paid | Examination procedure | 12.11.2019 | Examination requested [2020/08] | 30.08.2021 | Amendment by applicant (claims and/or description) | 29.11.2022 | Despatch of a communication from the examining division (Time limit: M06) | 30.06.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 08.09.2023 | Reply to a communication from the examining division | 05.08.2024 | Despatch of a communication from the examining division (Time limit: M04) | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 08.09.2023 | Request for further processing filed | 08.09.2023 | Full payment received (date of receipt of payment) Request granted | 18.09.2023 | Decision despatched | Fees paid | Renewal fee | 12.11.2019 | Renewal fee patent year 03 | 16.04.2021 | Renewal fee patent year 04 | 02.03.2022 | Renewal fee patent year 05 | 23.03.2023 | Renewal fee patent year 06 | 27.03.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2008137692 (LINK MEDICINE CORP [US], et al); | [Y]EP2508181 (KNOPP NEUROSCIENCES INC [US]); | [Y]JP2016113441 (OHARA YAKUHIN KOGYO KK); | International search | [Y]US5910319 (ANDERSON NEIL R [US], et al) [Y] 6-7 * ; column 1, lines 20-46; column 10, lines 12-21; column 12, lines 47-51 *; | [XY]US6667329 (MAJ JERZY [PL]) [X] 1, 3-5, 8, 10-13 * ; column 1, lines 15-19; column 2, lines 41-40; table 1; claims 1, 3, 5, 7, 9, 11-12, 17 * [Y] 2, 6-7, 9, 14-15; | [Y]US2013230569 (BOZIK MICHAEL E [US], et al) [Y] 14-15* ; claim 1 *; | [Y] - MARSH, L, "Depression and Parkinson's Disease: Current Knowledge", Current Neurology and Neuroscience Reports, (20131200), vol. 13, no. 12, pages 1 - 9, XP055543253 [Y] 2, 9 * ; title; abstract * DOI: http://dx.doi.org/10.1007/s11910-013-0409-5 |